Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Pneumonia, Bacterial D018410 16 associated lipids
Ventricular Fibrillation D014693 16 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Blister D001768 16 associated lipids
Scleroderma, Systemic D012595 16 associated lipids
Malabsorption Syndromes D008286 16 associated lipids
Subarachnoid Hemorrhage D013345 17 associated lipids
Escherichia coli Infections D004927 17 associated lipids
Leukemia, Myelogenous, Chronic, BCR-ABL Positive D015464 17 associated lipids
Respiratory Hypersensitivity D012130 18 associated lipids
Ischemia D007511 18 associated lipids
Albuminuria D000419 18 associated lipids
Lymphoma D008223 18 associated lipids
Pancreatitis, Acute Necrotizing D019283 18 associated lipids
Bronchial Spasm D001986 18 associated lipids
Dermatitis, Atopic D003876 19 associated lipids
Leukemia, Myeloid, Acute D015470 19 associated lipids
HIV Infections D015658 20 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Wounds and Injuries D014947 20 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Pleurisy D010998 20 associated lipids
Diabetic Angiopathies D003925 20 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Brain Edema D001929 20 associated lipids
Helicobacter Infections D016481 21 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Hypoxia-Ischemia, Brain D020925 22 associated lipids
Hypersensitivity D006967 22 associated lipids
Medulloblastoma D008527 22 associated lipids
Malaria, Falciparum D016778 22 associated lipids
Birth Weight D001724 23 associated lipids
Fibrosis D005355 23 associated lipids
Leukemia, T-Cell D015458 23 associated lipids
Hypoxia D000860 23 associated lipids
Cystitis D003556 23 associated lipids
Pulmonary Edema D011654 23 associated lipids
Cholestasis D002779 23 associated lipids
Pulmonary Fibrosis D011658 24 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Ascites D001201 25 associated lipids
Cerebrovascular Disorders D002561 25 associated lipids
Leukemia-Lymphoma, Adult T-Cell D015459 25 associated lipids
Encephalomyelitis, Autoimmune, Experimental D004681 26 associated lipids
Nasal Polyps D009298 26 associated lipids
Gastrointestinal Hemorrhage D006471 27 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Lenshof A and Laurell T Emerging clinical applications of microchip-based acoustophoresis. 2011 J Lab Autom pmid:22093301
Michelotto PV et al. Pulmonary inflammation due to exercise-induced pulmonary haemorrhage in Thoroughbred colts during race training. 2011 Vet. J. pmid:22108190
Côrte-Real R et al. The activity of platelet activating factor-acetyl hydrolase (PAF-AH) in the salivary glands of Rhodnius prolixus. 2011 J. Insect Physiol. pmid:21439293
Li XJ et al. [Expression of platelet-activating factor in necrotizing enterocolitis and its clinical significance]. 2011 Zhonghua Bing Li Xue Za Zhi pmid:21426810
Leistad L et al. Multiple phospholipase A2 enzymes participate in the inflammatory process in osteoarthritic cartilage. 2011 Scand. J. Rheumatol. pmid:21417548
Xu LF et al. Disruption of the F-actin cytoskeleton and monolayer barrier integrity induced by PAF and the protective effect of ITF on intestinal epithelium. 2011 Arch. Pharm. Res. pmid:21380808
Aktan I et al. PKC isoenzymes in equine platelets and stimulus induced activation. 2011 Vet. Immunol. Immunopathol. pmid:21513989
Jiang W et al. [Effects and mechanisms of platelet-activating factor on the invasiveness of ovarian cancer cells in vitro]. 2011 Zhonghua Fu Chan Ke Za Zhi pmid:22333285
Kang NI et al. Protein kinase CK2/PTEN pathway plays a key role in platelet-activating factor-mediated murine anaphylactic shock. 2011 J. Immunol. pmid:21531890
Tang WZ et al. Dimeric prenylated C6-C3 compounds from the stem bark of Illicium oligandrum. 2011 J. Nat. Prod. pmid:21524101
Ma SG et al. Four new phenolic diglycosides from the roots of Illicium oligandrum. 2011 Carbohydr. Res. pmid:21524732
Frisardi V et al. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer's disease pathology. 2011 Prog. Lipid Res. pmid:21703303
Musto AE and Samii M Platelet-activating factor receptor antagonism targets neuroinflammation in experimental epilepsy. 2011 Epilepsia pmid:21204830
Liao HJ et al. Two new ginkgolides from the leaves of Ginkgo biloba. 2011 Planta Med. pmid:21614751
Penna C et al. Platelet activating factor: the good and the bad in the ischemic/reperfused heart. 2011 Exp. Biol. Med. (Maywood) pmid:21378031
Kim HA et al. Mechanisms of platelet-activating factor-induced enhancement of VEGF expression. 2011 Cell. Physiol. Biochem. pmid:21325822
Ha SW and Lee CS Differential effect of platelet activating factor on 1-methyl-4-phenylpyridinium-induced cell death through regulation of apoptosis-related protein activation. 2010 May-Jun Neurochem. Int. pmid:20304020
Michelotto PV et al. Platelet-activating factor and evidence of oxidative stress in the bronchoalveolar fluid of Thoroughbred colts during race training. 2010 Mar-Apr J. Vet. Intern. Med. pmid:20102491
Ploppa A et al. Local anesthetic effects on human neutrophil priming and activation. 2010 Jan-Feb Reg Anesth Pain Med pmid:20048657
Ciprandi G and Cirillo I Rupatadine improves nasal symptoms, airflow and inflammation in patients with persistent allergic rhinitis: a pilot study. 2010 Apr-Jun J. Biol. Regul. Homeost. Agents pmid:20487631
Chomyszyn-Gajewska M [Evaluation of chosen salivary periodontal disease markers]. 2010 Prz. Lek. pmid:20687387
Thiele T et al. [Heparin-induced thrombocytopenia]. 2010 Internist (Berl) pmid:20694716
Jiang P et al. PMS-1077, a PAF antagonist, induced differentiation of HL-60 cells with its novel activity. 2010 Cell Biol. Int. pmid:20812915
Renteria LS et al. Prolonged hypoxia modulates platelet activating factor receptor-mediated responses by fetal ovine pulmonary vascular smooth muscle cells. 2010 Mol. Genet. Metab. pmid:20813571
Church MK Efficacy and tolerability of rupatadine at four times the recommended dose against histamine- and platelet-activating factor-induced flare responses and ex vivo platelet aggregation in healthy males. 2010 Br. J. Dermatol. pmid:20819087
Lin S et al. Abietane and C20-norabietane diterpenes from the stem bark of Fraxinus sieboldiana and their biological activities. 2010 J. Nat. Prod. pmid:20961093
He J et al. The induction of an angiogenic response in corneal myofibroblasts by platelet-activating factor (PAF). 2010 Curr. Eye Res. pmid:20961214
Rechka A et al. Identification of VEGF receptor-2 tyrosine phosphorylation sites involved in VEGF-mediated endothelial platelet-activating factor synthesis. 2010 Can. J. Physiol. Pharmacol. pmid:20962896
Soliman A et al. Platelet-activating factor induces TLR4 expression in intestinal epithelial cells: implication for the pathogenesis of necrotizing enterocolitis. 2010 PLoS ONE pmid:20976181
Gao F et al. [The levels of platelet-activating factor and nitric oxide synthase in bronchial asthma at high altitude]. 2010 Zhonghua Jie He He Hu Xi Za Zhi pmid:20979844
Zhu X et al. Effects of ropivacaine on adhesion molecule CD11b expression and function in human neutrophils. 2010 Int. Immunopharmacol. pmid:20348036
Zhao D et al. PAF exerts a direct apoptotic effect on the rat H9c2 cardiomyocytes in Ca2+-dependent manner. 2010 Int. J. Cardiol. pmid:19237210
Karantonis HC et al. Platelet-activating factor involvement in thioacetamide-induced experimental liver fibrosis and cirrhosis. 2010 Dig. Dis. Sci. pmid:19242794
Lefebvre JS et al. Toll-like receptor ligands induce polymorphonuclear leukocyte migration: key roles for leukotriene B4 and platelet-activating factor. 2010 FASEB J. pmid:19843712
Kida T et al. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models. 2010 Exp. Eye Res. pmid:20412793
Lorrain DS et al. Pharmacology of AM803, a novel selective five-lipoxygenase-activating protein (FLAP) inhibitor in rodent models of acute inflammation. 2010 Eur. J. Pharmacol. pmid:20519143
Salmon MD and Ahluwalia J Discrimination between receptor- and store-operated Ca(2+) influx in human neutrophils. 2010 Cell. Immunol. pmid:20716450
Ma J et al. Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells. 2010 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:19959817
Hasegawa S et al. Role of PAF receptor in proinflammatory cytokine expression in the dorsal root ganglion and tactile allodynia in a rodent model of neuropathic pain. 2010 PLoS ONE pmid:20454616
Yang L et al. Chronic alcohol exposure increases circulating bioactive oxidized phospholipids. 2010 J. Biol. Chem. pmid:20460374
Esquenazi S and Bazan HE Role of platelet-activating factor in cell death signaling in the cornea: A review. 2010 Mol. Neurobiol. pmid:20431963
Iyú D et al. The role of prostanoid receptors in mediating the effects of PGE(2) on human platelet function. 2010 Platelets pmid:20433310
Denizot Y Platelet-activating factor and acute myelogenous leukemia. 2010 Exp. Hematol. pmid:20303379
Zhou X and He P Endothelial [Ca2+]i and caveolin-1 antagonistically regulate eNOS activity and microvessel permeability in rat venules. 2010 Cardiovasc. Res. pmid:20080986
Kenchegowda S and Bazan HE Significance of lipid mediators in corneal injury and repair. 2010 J. Lipid Res. pmid:19965607
Jørgensen KM et al. Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2. 2010 Arch. Dermatol. Res. pmid:20041255
Coy Barrera ED and Cuca Suárez LE In vitro inhibitory activities of Lauraceae aporphine alkaloids. 2010 Nat Prod Commun pmid:20420312
Dyer KD et al. Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor. 2010 J. Immunol. pmid:20421642
Bate C et al. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation. 2010 J. Biol. Chem. pmid:20427265
Shin SH et al. Platelet-activating factor receptor mediates oxidized low density lipoprotein-induced migration of bone marrow-derived mesenchymal stem cells. 2010 Cell. Physiol. Biochem. pmid:21063106